In a research report published Tuesday, MLV analyst Vernon Bernardino maintained a Buy rating on Pluristem Therapeutics Inc. (NASDAQ:PSTI) with a price target …
MLV analyst Vernon Bernardino weighed in today with a few insights on NeoStem Inc (NASDAQ:NBS), as the company is expected to announce randomization of the first …
In a report that reiterated familiar growth strategies, MLV & Co. analyst Vernon Bernardino upgraded Coronado Biosciences Inc (NASDAQ:CNDO) to a Buy from a …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares climbed almost 10 percent in the last two days after the company’s competitor Genfit announced that its drug GFT505 had failed …
MLV’s healthcare analyst Vernon Bernardino weighed in with an optimistic view on Conatus Pharmaceuticals Inc (NASDAQ:CNAT), after the company announced positive top-line results from its double-blind, placebo-controlled …
MLV’s healthcare analyst Vernon Bernardino came out with a few insights on Galena Biopharma Inc (NASDAQ:GALE), after the company announced expansion of targeted patient population for its ongoing …
MLV analyst Vernon Bernardino was out pounding the table on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), reiterating a Buy rating and price target of $15, which represents a …
MLV analyst Vernon Bernardino was out pounding the table on Galena Biopharma Inc (NASDAQ:GALE) Monday, reiterating a Buy rating and a $5 price target, …
In a research report released today, MLV analyst Vernon Bernardino initiated coverage on shares of Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) with a Buy rating and …
In a research report published after market close today, MLV & Co. analyst Vernon Bernardino initiated coverage on shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) with …
